Anne-Laure joined the Board of Gene Predictis in January 2023 and is part of Apposite Capital. She joined Apposite in 2015, where she is involved in originating, executing and managing investments. She currently sits on the Boards of Swanton Care & Community, NIMGenetics, 1MED and I2A. She has over 15 years experience in private equity and M&A. She most recently was CFO of Nuage Labs a Paris-based technology start-up. She was previously an Associate in the investment team at Bridgepoint Capital where she focused on investment execution and due diligence. She started her career in 2009 within the Rothschild Global Financial Advisory group where she worked on a number of high-profile deals in the European healthcare sector.

Anne-Laure is a graduate of ESCP Europe and a CFA charter holder.